[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]

Area of Science:

• Immunology
• Vaccinology
• Epidemiology

Background:

• Pertussis (whooping cough) cases have increased in Poland since the 1990s, particularly among adolescents and adults.
• High immunization status is maintained in neonates and children, suggesting waning immunity or other factors contributing to the resurgence.

Purpose of the Study:

• To evaluate the current immunogenicity and reactogenicity of pertussis acellular vaccines.
• To assess the effectiveness of these vaccines in different age groups, especially adolescents and adults.

Main Methods:

• Review of current literature on pertussis acellular vaccines.
• Analysis of immunogenicity and reactogenicity data across various age demographics.
• Focus on vaccine effectiveness in prolonging immunity against pertussis.

Main Results:

• Acellular pertussis vaccines are widely used for adolescent and adult immunization.
• Data suggests these vaccines may play a role in prolonging immunity.
• Variations in immunogenicity and reactogenicity observed across different age groups.

Conclusions:

• Pertussis acellular vaccines are crucial for addressing the resurgence in adolescent and adult populations.
• Further research is needed to optimize vaccination strategies for sustained pertussis protection.
• Understanding vaccine-induced immunity duration is key to controlling pertussis outbreaks.